Quantitation of microcirculatory abnormalities in patients with primary Raynaud's phenomenon and systemic sclerosis by video capillaroscopy

Rheumatology

Volumn 39, Issue 5, 2000, Pages 506-512

  Bukhari, M ^a   Hollis, S ^b   Moore, T ^a   Jayson, M I V ^a   Herrick, A L ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b LANCASTER UNIVERSITY   (United Kingdom)

Author keywords

Capillary dimensions; Nailfold video capillaroscopy; Raynaud's phenomenon; Systemic sclerosis

Indexed keywords

ADULT; ARTICLE; CAPILLAROSCOPY; CAPILLARY; CAPILLARY DENSITY; CAPILLARY FLOW; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FINGER NAIL; HUMAN; MALE; OBSERVER VARIATION; PRIORITY JOURNAL; RAYNAUD PHENOMENON; REPRODUCIBILITY; SYSTEMIC SCLEROSIS; VIDEORECORDING;

EID: 0034039051     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/39.5.506     Document Type: Article

References (25)

1. Maricq HR, LeRoy EC. Patterns of finger capillary abnormalities in connective tissue disease by 'wide-field' microscopy. Arthritis Rheum 1973;16:619-28.
2. Luggen M, Belhorn L, Evans T, Fitzgerald O, Spencer-Green G. The evolution of Raynaud's phenomenon: a longterm prospective study. J Rheumatol 1995;22: 2226-32.
3. Bukhari M, Herrick AL, Moore T, Manning J, Jayson MIV. Increased nailfold capillary dimensions in primary Raynaud's phenomenon and systemic sclerosis. Br J Rheumatol 1996;35:1127-31.
4. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
5. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
6. Bukhari M, Moore T, Jayson MIV, Herrick AL. Nailfold capillary dimensions in patients with primary Raynaud's phenomenon, limited cutaneous systemic sclerosis, diffuse systemic sclerosis and healthy controls. Br J Rheumatol 1997;36(Abstr. Suppl. 2):31.
7. Bukhari M, Moore T, Jayson MIV, Herrick AL. Nailfold capillary dimensions in patients with primary Raynaud's phenomenon, limited cutaneous systemic sclerosis and diffuse systemic sclerosis and their comparisons with healthy controls. Arthritis Rheum 1997;40(Suppl.):S254.
8. Scheja A, Akesson A, Niewierowicz I, Wallin L, Wildt M, Wollheim FA. Computer based quantitative analysis of capillary abnormalities in systemic sclerosis and its relation to plasma concentrations of von Willebrand factor. Ann Rheum Dis 1996;55:52-6.
9. Wigley FM, Wise RA, Miller R, Needleman BW, Spence RJ. Anticentromere antibody as a predictor of digital ischemic loss in patients with systemic sclerosis. Arthritis Rheum 1992;35:688-93.
10. Clark S, Campbell F, Moore T, Jayson MIV, King TA, Herrick AL. Laser Doppler imaging - a new technique for quantifying microcirculatory flow in patients with primary Raynaud's phenomenon and systemic sclerosis. Microvasc Res 1999;57:284-91.
11. Kabasakal Y, Elvins DM, Ring EFJ, McHugh NJ. Quantitative nailfold microscopy findings in a population with connective tissue disease and in normal healthy controls. Ann Rheum Dis 1996;55:507-12.
12. Studer A, Hunziker T, Lutolf O, Schmidli J, Chen D, Mahler F. Quantitative nailfold capillary microscopy in cutaneous and systemic lupus erythematosus and localized and systemic scleroderma. J Am Acad Dermatol 1991;24:941-5.
13. Mahler F, Saner H, Boss C, Annaheim M. Local cold exposure test for capillaroscopic examination of patients with Raynaud's syndrome. Microvasc Res 1987;33:422-7.
14. Jacobs MJMM, Lemmens HAJ. Microcirculatory changes in patients with primary Raynaud's phenomenon after treatment with buflomedil. Int J Microcirc Clin Exp 1985;4:63-8.
15. Hahn M, Klyscz T, Junger M, Rassner G. Local cold exposure test as therapy control in patients with Raynaud's phenomenon: comparison between laser Doppler fluxmetry and simultaneous red blood cell velocity measurements in nailfold capillaries. Br J Dermatol 1995;133:704-9.
16. Bollinger A, Jager K, Siegenthaler W. Microangiopathy of progressive systemic sclerosis. Evaluation by dynamic fluorescence videomicroscopy. Arch Intern Med 1986; 146:1541-5.
17. Grassi W, Core P, Carlino G, Cervini C. Acute effects of single dose nifedipine on cold-induced changes of microvascular dynamics in systemic sclerosis. Br J Rheumatol 1994;33:1154-61.
18. Houtman PM, Kallenberg CGM, Fidler V, Wouda AA. Diagnostic significance of nailfold capillary patterns in patients with Raynaud's phenomenon. J Rheumatol 1986;13:556-63.
19. Lefford F, Edwards JCW. Nailfold capillary microscopy in connective tissue disease: a quantitative morphological analysis. Ann Rheum Dis 1986;45:741-9.
20. Statham BN, Rowell NR. Quantification of the nail fold capillary abnormalities in systemic sclerosis and Raynaud's syndrome. Acta Derm Venereol (Stockh) 1986;66:139-43.
21. Carpentier PH, Maricq HR. Microvasculature in systemic sclerosis. Rheum Dis Clin North Am 1990;16:75-91.
22. Michoud E, Poensin D, Carpentier PH. Digitized nailfold capillaroscopy. Vasa 1994;23:35-42.
23. Andrade LEC, Gabriel A, Assad RL, Ferrari AJL, Atra E. Panoramic nailfold capillaroscopy: a new reading method and normal range. Semin Arthritis Rheum 1990;20:21-31.
24. Allen PD, Taylor CJ, Herrick AL, Moore T. Image analysis of nail-fold capillary patterns. Proc Med Image Understanding Anal 1998;77-80.
25. Herrick AL, Rieley F, Schofield D, Hollis S, Braganza JM, Jayson MIV. Micronutrient antioxidant deficiency in patients with primary Raynaud's phenomenon and systemic sclerosis. J Rheumatol 1994;21:1477-83.